Community Spirit Award

National Alzheimer’s Coordinating Center

Junior Investigator Award

Turken Research Prize

P. Gene and Elaine Smith Term Chair

Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials

Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer’s disease: study partner vs. participant accuracy

Response to “Avoiding Methodological Bias in Studies of Amyloid Imaging Results Disclosure”

Retention of Alzheimer Disease Research Participants

Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?

If you haven’t heard, there’s been big news recently about Alzheimer’s disease. Over the past year, the Food and Drug Administration has approved two new treatments that may slow the cognitive decline in people with dementia, and studies are under way to see if these treatments possibly delay or prevent the onset of Alzheimer’s. To help us understand these developments, Dr. Joshua Grill is joining the UCI Podcast. Dr. Grill is the director of the Institute for Memory Impairments and Neurological Disorders at UCI, better known as UCI MIND.

The latest about Alzheimer's disease

In 1965, the University of California, Irvine was founded with a mission to catalyze the community and enhance lives through rigorous academics, cutting-edge research, and dedicated public service. Today, we draw on the unyielding spirit of our pioneering faculty, staff and students who arrived on campus with a dream to inspire change and generate new ideas. We believe that true progress is made when different perspectives come together to advance our understanding of the world around us. And we enlighten our communities and point the way to a better future. At UCI, we shine brighter.

UC Irvine

Dr. Grill has been the recipient of the National Alzheimer’s Coordinating Center Junior Investigator Award, the Alzheimer’s Association Turken Research Prize, the Community Spirit Award from OPICA Adult Day Services, and the P. Gene and Elaine Smith Term Chair in Alzheimer’s Disease Research. He has been funded by the National Institute on Aging, the National Institute of Neurological Disorders and Stroke, the Alzheimer’s Association, the Hartford Foundation, the BrightFocus Foundation, the American Federation for Aging Research, and the University of California. He is the co-leader of the Recruitment Unit and the Internal Ethics Committee for the NIH-funded Alzheimer’s Clinical Trial Consortium. He is a member of the Scientific Advisory Board for Maria Shriver’s Women’s Alzheimer’s Movement and for Lauren Rogen Miller and Seth Rogan's HfC. In 2017, he co-chaired a workgroup as part of the NIH’s Inclusion Across the Lifespan workshop, a congressional mandate in the 21st Century Cures Act (P.L. 114-255). He was part of a working group sponsored by the National Institute on Aging and the Alzheimer’s Association charged with creating a national strategy for recruitment to Alzheimer’s disease clinical research.

Neuroscience

Clinical Trials

Alzheimer’s Disease

Neurodegenerative disorders

Recruitment and Retention

UCI Faculty Profile

Google Scholar Citations

ResearchGate Citations

New Alzheimer’s drugs bring hope. But not equally for all patients.

Sound waves get Alzheimer’s drug past brain barrier, small study shows

Meet Orange County’s 125 most influential people for 2023

Researchers testing out drug for Alzheimer's prevention

Alzheimer’s drug trials plagued by lack of racial diversity

Insight: Promising new Alzheimer's drugs may benefit whites more than Blacks

Potential Benefit of Nicotinamide Observed in Proof-Of-Concept Trial of Alzheimer Disease

OC 50 2023 – 50 Shaping the Future of Healthcare in OC

About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities and is ranked among the nation’s top 10 public universities by U.S. News & World Report. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 36,000 students and offers 224 degree programs. It’s located in one of the world’s safest and most economically vibrant communities and is Orange County’s second-largest employer, contributing $7 billion annually to the local economy and $8 billion statewide. For more on UCI, visit www.uci.edu.

The UCI Podcast

Director of the Institute for Memory Impairments and Nerological Disorders at UCI

Presented to ITPC EverGreen Senior Class on September 13, 2017
Video credit: Ching-Hao Shaw

Maximizing Healthy Brain Aging- Joshua Grill, PhD &amp; Ruobing Li, MA

UCLA assistant professor Joshua D. Grill, PhD, discusses research advances in understanding Alzheimer's disease and how they are being translated into investigational therapies that are currently being tested in clinical trials.

Learn more at http://uclahealth.org/UCLAMDChat

Research-Promising Therapies for Dementia Patients | Joshua D. Grill, PhD - UCLA Health

UCI C2C Registry - Joshua Grill, PhD

Select Inquiry Type